Great Lakes Advisors LLC purchased a new stake in Ventas, Inc. (NYSE:VTR – Free Report) in the second quarter, Holdings Channel.com reports. The institutional investor purchased 7,753 shares of the real estate investment trust’s stock, valued at approximately $688,000.
Other hedge funds also recently added to or reduced their stakes in the company. Angeles Wealth Management LLC raised its holdings in Ventas by 4.0% during the first quarter. Angeles Wealth Management LLC now owns 3,329 shares of the real estate investment trust’s stock worth $274,000 after purchasing an additional 128 shares in the last quarter. IHT Wealth Management LLC lifted its position in shares of Ventas by 3.2% during the 4th quarter. IHT Wealth Management LLC now owns 4,415 shares of the real estate investment trust’s stock worth $343,000 after buying an additional 137 shares during the last quarter. Sequoia Financial Advisors LLC boosted its holdings in shares of Ventas by 1.2% in the 1st quarter. Sequoia Financial Advisors LLC now owns 12,894 shares of the real estate investment trust’s stock valued at $1,054,000 after buying an additional 148 shares in the last quarter. Parallel Advisors LLC boosted its holdings in shares of Ventas by 4.6% in the 3rd quarter. Parallel Advisors LLC now owns 3,970 shares of the real estate investment trust’s stock valued at $278,000 after buying an additional 175 shares in the last quarter. Finally, Manchester Capital Management LLC grew its position in shares of Ventas by 60.5% in the 4th quarter. Manchester Capital Management LLC now owns 491 shares of the real estate investment trust’s stock valued at $38,000 after buying an additional 185 shares during the last quarter. 94.18% of the stock is currently owned by hedge funds and other institutional investors.
Ventas Stock Performance
Shares of VTR opened at $93.32 on Friday. The company has a current ratio of 0.44, a quick ratio of 0.44 and a debt-to-equity ratio of 0.86. The firm has a market cap of $47.87 billion, a PE ratio of 172.81, a price-to-earnings-growth ratio of 2.15 and a beta of 0.69. The company’s 50 day simple moving average is $91.36 and its 200-day simple moving average is $87.08. Ventas, Inc. has a 12-month low of $66.38 and a 12-month high of $101.60.
Insider Buying and Selling
In other Ventas news, Director Michael J. Embler acquired 2,500 shares of the company’s stock in a transaction on Wednesday, June 3rd. The shares were bought at an average cost of $78.81 per share, for a total transaction of $197,025.00. Following the completion of the purchase, the director owned 19,202 shares in the company, valued at $1,513,309.62. This trade represents a 14.97% increase in their position. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 0.53% of the company’s stock.
Wall Street Analyst Weigh In
VTR has been the topic of several research analyst reports. Raymond James Financial initiated coverage on shares of Ventas in a research note on Tuesday, June 16th. They set an “outperform” rating and a $94.00 price target on the stock. JPMorgan Chase & Co. upped their price objective on shares of Ventas from $93.00 to $94.00 and gave the company an “overweight” rating in a research note on Monday, May 11th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a $100.00 price objective on shares of Ventas in a report on Tuesday, June 16th. Cantor Fitzgerald lifted their target price on Ventas from $97.00 to $102.00 and gave the stock an “overweight” rating in a research report on Friday, July 31st. Finally, The Goldman Sachs Group reissued a “buy” rating and issued a $110.00 target price on shares of Ventas in a report on Tuesday, May 19th. Fifteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, Ventas has an average rating of “Moderate Buy” and an average price target of $98.00.
Check Out Our Latest Stock Analysis on VTR
About Ventas
Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.
Ventas’ business model combines property ownership with active asset management and capital markets activity.
Read More
- Five stocks we like better than Ventas
- 2 Biotech Stocks Shaping Up for Major Breakouts
- 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs
- 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run
- Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?
Want to see what other hedge funds are holding VTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ventas, Inc. (NYSE:VTR – Free Report).
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.
